ConductScience.org, home

Trial · NCT07889778

Learning to Communicate Successfully Approach for Urdu Speaking Patients With Chronic Aphasia

NCT07889778, Not applicable, Completed, University of Lahore

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Learning to Communicate Successfully Approach for Urdu Speaking Patients With Chronic Aphasia. Trials, record NCT07889778. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889778

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Learning to Communicate Successfully Approach for Urdu Speaking Patients With Chronic Aphasia
NCT number
NCT07889778
Status
Completed
Phases
Not applicable
Enrollment
30 participants, actual
Lead sponsor
University of Lahore
Conditions
Aphasia
Interventions
Learning to Communicate Successfully Approach (LCSA)
First posted
2026-10-22
Last updated
2026-10-29

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAphasia Severity and Language FunctionBaseline and immediately after completion of the intervention.
Aphasia severity and language function will be assessed using the Quick Aphasia Battery (QAB). The QAB summary scores range from 0 to 10, with a minimum score of 0 and a maximum score of 10. Higher scores indicate better language function, whereas lower scores indicate greater language impairment. Time Frame: Baseline and immediately after completion of the intervention.
SecondaryImpact of Aphasia on Quality of LifeBaseline and immediately after completion of the intervention.
The impact of aphasia on quality of life will be assessed using the Aphasia Impact Questionnaire-21 (AIQ-21). The total score ranges from a minimum of 0 to a maximum of 84. Higher scores indicate a greater impact of aphasia on the individual's life, whereas lower scores indicate a lesser impact and a better outcome. Time Frame: Baseline and immediately after completion of the intervention.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07889778

GET https://conductscience.org/api/trials/v1/NCT07889778/registered